Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Issued on behalf of GT Biopharma, Inc. VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The U.S. oncology market is projected to surge from $81 billion in 2025 to $212 billion by 2034[1], driven by a fundamental s
(Financial Post, 2025-12-24T11:02:13Z)